Overexpression of c-met proto-oncogene associated with chromophilic renal cell carcinoma with papillary growth

Virchows Archiv

Volumn 433, Issue 6, 1998, Pages 511-515

  Inoue, Keiji ^a   Karashima, Takashi ^a   Chikazawa, Masakazu ^a   Iiyama, Tatsuo ^a   Yoshikawa, Chiaki ^a   Furihata, Mutsuo ^a   Ohtsuki, Yuji ^a   Shuin, Taro ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

c MET; Chromophilic subtype; Immunohistochemistry; Papillary growth pattern; Renal cell carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGED; ARTICLE; CELL ONCOGENE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY PAPILLA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 0031797830     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050282     Document Type: Article

References (28)

1. Di Renzo MF, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, Gaglia P, Zara P, Comoglio (1991) Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 6:1997-2003
2. Di Renzo MF, Poulsom R, Olivero M, Comoglio PM, Lemoine NR (1995) Expression of the Met/Hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res 55:1129-1138
3. Di Renzo MF, Olivero M, Ferro S, Prat M, Bongarzone (1992) Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 7:2549-2553
4. Furlong RA, Takehara T, Taylor WG, Nakamura T, Rubin JS (1991) Comparison of biological and immunochemical properties indicates that scatter factor and hepatocyte growth factor are indistinguishable. J Cell Sci 100:173-177
5. Igawa T, Kanda S, Kanatake H, Saitoh Y, Ichihara A, Tomita Y, Nakamura T (1991) Hepatocyte growth factor is a potent mitogen for cultured rabbit tubular epithelial cells. Biochem Biophys Res Commun 174:831-838
6. Inoue K, Furihata M, Otsuki Y, Fujita Y (1993) Distribution of S-100 protein - positive dendritic cells and expression of HLA-DR antigen in transitional cell carcinoma of the urinary bladder in relation to tumor progression and prognosis. Virchow Arch [A] 422:351-355
7. Markowitz S, Wang J, Myeroff L, Parsons R, Scen L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW. Vogelstein B, Brattain M, Wilson KV (1995) Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338
8. Massague J (1990) Transforming growth factor-α. J Biol Chem 265:21393-21396
9. Matsumoto K, Hashimoto K, Yoshikawa K, Nakamura T (1991) Marked stimulation of growth and motility of human keratinocytes by hepatocyte growth factor. Exp Cell Res 196: 114-120
10. Montesano R, Scaller G, Orci L (1991) Indication of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors. Cell 66:697-711
11. Natali PG, Prat M, Nicotra MR, Bigotti A, Olivero M, Comoglio PM, Di Renzo MF (1996) Overexpression of the met/ HGF receptor in renal cell carcinomas. Int J Cancer 69:212-217
12. Oda H, Nakatsuru Y, Ishikawa T (1995) Mutation of p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas. Cancer Res 55: 658-662
13. Park K, Kim S, Bang Y, Park J, Kim NK, Roberts AB, Sporn MB (1994) Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA 91:8772-8776
14. Partanen AM (1990) Epidermal growth factor and transforming growth factor-a in the development of epithelialmesenchymal organs of the mouse. Curr Top Dev Biol 24: 31-55
15. Rios MA, Macias A, Perez R, Lage A, Skoog L (1988) Receptors for epidermal growth factor and estrogen as predictors of relapse in patients with mammary carcinoma. Anticancer Res 8:173-176
16. Roberts AB (1985) Type β transforming growth factors: a bifunctional regulator of cellular growth. Proc Natl Acad USA 82:119-123
17. Rubin JS, Chan AM, Bottaro DP, Burgess WH, Taylor WG, Cech AC, Hirschfield DW, Wong J, Miki T, Finch PW, Aaronson SA (1991) A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci USA 88:415-419
18. Sainsbury JR, Malcolum AJ, Appleton DR, Farndon JR, Harris AL (1985) Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol 38:1225-1228
19. Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidaram A, Bergerheim UR, Feltis JT, Casadevall C, Zamarron A, Bernues M, Richard S, Lips CJM, Walther MM, Tsui LC, Geil L, Orcutt ML, Stackhouse T, Lipan J, Slife L, Brauch H, Decker J, Niehans G, Hughson MD, Moch H, Störkel S, Lerman MI, Linehan WM, Zbar B (1997) Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16: 68-73
20. Shimizu K, Aizawa S, Yamabe H (1992) Histological classification of renal cell carcinoma. In: Machida T (ed) General rule for clinical and pathological studies on renal cell carcinoma. Japanese Urological Association, The Japanese Pathological Society, and Japan Radiological Society, Tokyo, pp 78-91
21. Shiota G, Rhoads DB, Nakamura T, Schmidt EV (1991) Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci USA 88:373-377
22. Shuin T, kondou K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B, Lerman MI, Yao M (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54: 2852-2855
23. Speicher MR, Schoell B, Manoir S, Schroch E, Ried T, Cremer T, Störkel S, Kovacs A, Kovacs G (1994) Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am J Pathol 145:356-364
24. Stumm G, Eberwein S, Wolf SR, Stein H, pomer S, Schlegel J, Waldherr R (1996) Concomitant overexpression of the EGFR and erbB-2 genes in renal cell carcinoma (RCC) is correlated with differentiation and metastasis. Int J Cancer 69: 17-22
25. Tajima H, Matsumoto K, Nakamura T (1991) Inhibitory effect of HGF on various carcinoma cells. FEBS Lett 291:229-232
26. Thoenes W, Störkel ST, Rumpelt HJ, Moll R (1990) Cytomorphological typing of renal cell carcinoma - a new approach. Eur Urol 18:6-9
27. Yao M, Shuin T, Misaki H, Kubota Y (1988) Enhanced expression of c-myc and epidermal growth factor receptor (c-erb-B1) genes in primary human renal cancer. Cancer Res 48: 6753-675
28. Yasui W, Sumiyoshi H, Hara J, Kameda T, Ochiai A, Ito H, Tahara E (1988) Expression of epidermal growth factor receptor in human gastric and colonie carcinomas. Cancer Res 48: 137-141